• 510 Citations
  • 13 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessandra Dicitore is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Neuroendocrine Tumors Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Interferons Medicine & Life Sciences
Interferon Type I Medicine & Life Sciences
Seminal Vesicle Secretory Proteins Medicine & Life Sciences
Vasoactive Intestinal Peptide Medicine & Life Sciences
Zebrafish Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 510 Citations
  • 13 h-Index
  • 36 Article
  • 3 Review article
2 Citations (Scopus)

Precision medicine in neuroendocrine neoplasms: An update on current management and future perspectives

Gaudenzi, G., Dicitore, A., Carra, S., Saronni, D., Pozza, C., Giannetta, E., Persani, L. & Vitale, G., Jan 1 2019, In : European Journal of Endocrinology. 181, 1, p. R1-R10

Research output: Contribution to journalReview article

Open Access
Precision Medicine
Neoplasms
Tertiary Prevention
Neurosecretory Systems
Therapeutics

Pasireotide in the treatment of neuroendocrine tumors: a review of the literature

Vitale, G., Dicitore, A., Sciammarella, C., Di Molfetta, S., Rubino, M., Faggiano, A. & Colao, A., Jun 2018, In : Endocrine-Related Cancer. 25, 6, p. R351-R364

Research output: Contribution to journalReview article

Neuroendocrine Tumors
Somatostatin
Octreotide
pasireotide
Growth
6 Citations (Scopus)

Pasireotide in the treatment of neuroendocrine tumors: A review of the literature

Vitale, G., Dicitore, A., Sciammarella, C., Di Molfetta, S., Rubino, M., Faggiano, A. & Colao, A., Jun 1 2018, In : Endocrine-Related Cancer. 25, 6, p. R351-R364

Research output: Contribution to journalReview article

Neuroendocrine Tumors
Somatostatin
Octreotide
pasireotide
Growth

8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth

Grassi, E. S., Dicitore, A., Negri, I., Borghi, M. O., Vitale, G. & Persani, L., May 2017, In : Endocrine. 56, p. 388–398 11 p.

Research output: Contribution to journalArticle

Thyroid Neoplasms
Cyclic AMP
Cyclic AMP-Dependent Protein Kinases
Growth
Cell Proliferation